MacLusky NJ, Cook S, Scrocchi L, Shin J, Kim J, Vaccarino F et al (2000) Neuroendocrine function and response to stress in mice with complete disruption of glucagon-like peptide-1 receptor signaling
REDEFINE 2 (combination, with type 2 diabetes) In adults with type 2 diabetes, the combination achieved 13.7% weight reduction versus 3.4% for placebo
These microvascular benefits are demonstrated in patients without DR who were less likely to develop retinopathy after treatment with GLP-1 agonists
The complementary mechanisms have generated clinical interest in combination therapy
A person may experience missing portions of vision (visual field defects) or disc swelling, which is visible upon examination of the eye
Make sure the pharmacy you choose is licensed and follows proper guidelines for compounding medications